Safety and Efficacy of Tigecycline in the Treatment of C. Difficile Associated Diarrhea(CDAD).

Trial Profile

Safety and Efficacy of Tigecycline in the Treatment of C. Difficile Associated Diarrhea(CDAD).

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Oct 2013

At a glance

  • Drugs Tigecycline (Primary)
  • Indications Clostridium infections; Diarrhoea
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 23 Jan 2012 Planned end date changed from 1 Jul 2012 to 1 Jul 2013 as reported by ClinicalTrials.gov.
    • 23 Jan 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top